Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cosentyx
Cosentyx
Novartis Wins U.S. Approval for First of New Psoriasis Drugs
Bloomberg
Wed, 01/21/15 - 05:46 pm
Novartis
FDA
psoriasis
Cosentyx
Here’s What Cosentyx’s Approval In Japan Means For Novartis
Bidness Etc.
Mon, 12/29/14 - 10:57 am
Cosentyx
Japan
drug approvals
Novartis
psoriatic arthritis
Is this the future of late-stage drug development? Lets hope so!
Forbes
Mon, 12/15/14 - 10:19 am
R&D
drug development
Stelara
JNJ
psoriasis
Novartis
Cosentyx
Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Motley Fool
Mon, 12/15/14 - 08:50 am
Novartis
Amgen
JNJ
Stelara
psoriasis
brodalumab
Cosentyx
Novartis' Enbrel beater bounds toward psoriasis approval ahead of the crowd
Fierce Biotech
Fri, 11/21/14 - 10:30 am
Novartis
Enbrel
psoriasis
Cosentyx
Pages
« first
‹ previous
1
2
3
4